Unspecified Janus kinase (JAK) inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified Janus kinase (JAK) inhibitor, covering 2024-11-25 to 2024-11-25. Get the full timeline:
Most recent: Clinical Trial Update: Janus Kinase Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction [Phase 2]